The human antibody response against HIV-1 infection recognizes diverse antigenic sub-units of the virion, and includes a high level of antibodies to the Gag protein. We report here the isolation and characterization of a subset of Gag-specific human monoclonal antibodies (mAbs) that were prevalent in the antibody repertoire of an HIV-infected individual. Several lineages of Gag-specifc mAbs were encoded by a single antibody heavy chain variable region, VH4-59, and a representative antibody from this group designated mAb 3E4 recog-nized a linear epitope on the globular head of the p17 subunit of Gag. We found no evidence that mAb 3E4 exhibited any function in laboratory studies aimed at elucidating the immuno-logic activity, including assays...
The HIV-1 envelope glycoprotein (Env) trimer is the key target for vaccines aimed at inducing neutra...
Multiple antibody effector functions arise in HIV-1 infection that could be harnessed to protect aga...
Antibodies that mediate killing of HIV-infected cells through antibody-dependent cellular cytotoxici...
The CD4 binding site (CD4bs) on the envelope glycoprotein is a major site of vulnerability that is c...
textabstractOBJECTIVE: The aim of this study is to characterize antigenic sites on HIV-1 gp120 which...
The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for broadly ...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
<div><p>A biased usage of immunoglobulin (Ig) genes is observed in human anti-HIV-1 monoclonal antib...
A biased usage of immunoglobulin (Ig) genes is observed in human anti-HIV-1 monoclonal antibodies (m...
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of ...
Antibodies (Abs) produced during HIV-1 infection rarely neutralize a broad range of viral isolates; ...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
HIV-1 envelope glycoproteins (Env) are the only viral antigens present on the virus surface and serv...
The F105 mAb, identified in an HIV-1-infected individual, binds to a discontinuous epitope on the HI...
Lectin-like molecules and their receptors are cell surface molecules that have been shown to play a ...
The HIV-1 envelope glycoprotein (Env) trimer is the key target for vaccines aimed at inducing neutra...
Multiple antibody effector functions arise in HIV-1 infection that could be harnessed to protect aga...
Antibodies that mediate killing of HIV-infected cells through antibody-dependent cellular cytotoxici...
The CD4 binding site (CD4bs) on the envelope glycoprotein is a major site of vulnerability that is c...
textabstractOBJECTIVE: The aim of this study is to characterize antigenic sites on HIV-1 gp120 which...
The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for broadly ...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
<div><p>A biased usage of immunoglobulin (Ig) genes is observed in human anti-HIV-1 monoclonal antib...
A biased usage of immunoglobulin (Ig) genes is observed in human anti-HIV-1 monoclonal antibodies (m...
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of ...
Antibodies (Abs) produced during HIV-1 infection rarely neutralize a broad range of viral isolates; ...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
HIV-1 envelope glycoproteins (Env) are the only viral antigens present on the virus surface and serv...
The F105 mAb, identified in an HIV-1-infected individual, binds to a discontinuous epitope on the HI...
Lectin-like molecules and their receptors are cell surface molecules that have been shown to play a ...
The HIV-1 envelope glycoprotein (Env) trimer is the key target for vaccines aimed at inducing neutra...
Multiple antibody effector functions arise in HIV-1 infection that could be harnessed to protect aga...
Antibodies that mediate killing of HIV-infected cells through antibody-dependent cellular cytotoxici...